C
Coherus Oncology, Inc. (CHRS)
NGM – Real vaqt narxi. Valyuta: USD
1.17
-0.04 (-2.88%)
Yopilishda: Aug 12, 2026, 3:59 PM EDT
1.20
+0.03 (2.56%)
Bozordan keyin: Aug 12, 2026, 4:28 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NGM – Real vaqt narxi. Valyuta: USD
1.17
-0.04 (-2.88%)
Yopilishda: Aug 12, 2026, 3:59 PM EDT
1.20
+0.03 (2.56%)
Bozordan keyin: Aug 12, 2026, 4:28 PM EDT
No Data
Ushbu aksiya uchun yangiliklar yo'q.
Kompaniyaning naqd pul zahiralari $82.9M umumiy qarzdan $54.2M sezilarli darajada ko'p bo'lib, kuchli moliyaviy moslashuvchanlikni ta'minlaydi
Jami joriy aktivlar $133.8M jami joriy majburiyatlardan $75.5M ko'p bo'lib, ajoyib likvidlikni ta'kidlaydi
Qarz/kapital nisbati (0.9) tarmoq o'rtachasiga yaqin bo'lib, muvozanatli leverajni aks ettiradi
Foiz qoplash koeffitsiyenti (-13.9x) xavfli darajada past bo'lib, qarzni qaytarish xavflarini ko'rsatadi
Salbiy erkin pul oqimi -$62.1M kompaniyaning qayta investitsiya qilish yoki qarzni to'lash qobiliyatini cheklaydi
| KO‘RSATKICH NOMI | KO‘RSATKICH | SANOAT O‘RTACHASI | 5 YILLIK TREND | BALL |
|---|---|---|---|---|
| Joriy likvidlik ko'rsatkichi | 1.77 | 6.05 | 9.0 | |
| Tezkor likvidlik nisbati | 1.70 | 5.63 | 8.0 | |
| Qarz/Kapital nisbati | 0.89 | 0.30 | 6.0 | |
| Qarz/Aktivlar nisbati | 0.28 | 1.04 | 7.0 | |
| Foiz to‘lov qoplami | -13.92 | -16.91 | 1.0 | |
| O‘rtacha ball | 6.2 | |||
| KO‘RSATKICH | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Jami daromad | 211M | 257M | 26M | 42M | 51M |
| Yalpi foyda | 137M | 94M | 12M | 24M | 32M |
| Operatsion daromad | -257M | -193M | -193M | -180M | -157M |
| Sof foyda | -292M | -238M | -148M | -170M | -131M |
| EBITDA | -253M | -189M | -188M | -176M | -153M |
| Nomi | DAROMAD O'SISHI | EPS O‘SISHI | BALL |
|---|---|---|---|
| Joriy chorak | 38.38 | 30.32 | 10 |
| Keyingi chorak | 42.74 | 44.44 | 10 |
| Joriy yil | 43.74 | 40.77 | 10 |
| Keyingi yil | 45.38 | 33.62 | 10 |
| O‘rtacha ball | 10 | ||
| NOMI | DAROMAD | SOF FOYDA | EPS | FCF | BALL |
|---|---|---|---|---|---|
| Chorak/Chorak | 16.22 | 46.44 | 18.52 | -7.25 | 7.3 |
| Yil/Yil | 39.53 | 50.84 | 43.59 | -33.14 | 7.8 |
| 3 yil o‘rtacha | -2.67 | 13.74 | -193.79 | -153.78 | 2.8 |
| 5 yil o‘rtacha | -14.94 | -55.49 | -183.04 | -223.13 | 1.0 |
| O‘rtacha ball | 4.7 | ||||
Insufficient positive free cash flow for DCF analysis
| NOMI | JORIY | SANOAT | BALL |
|---|---|---|---|
| Dividend foizi | 0.00 | N/A | 1.0 |
| To'lov koeffitsienti | 0.00 | N/A | 1.0 |
| 5 yillik dividend o‘sishi | N/A | N/A | 1.0 |
| Dividend oshgan yillar | N/A | N/A | 1.0 |
| O‘rtacha ball | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NOMI | MASSHTAB | BALL |
|---|---|---|
| Bozor ulushi | Yo'q | 1.0 |
| Nomoddiy aktivlar | Yo'q | 1.0 |
| O'zgartirish xarajatlari | Yo'q | 1.0 |
| Tarmoq ta'siri | Yo'q | 1.0 |
| Masshtab ta'siri | Yo'q | 1.0 |
| O‘rtacha ball | 1.0 | |